Non-Viral Drug Delivery Systems Market, By Molecules (Small Molecules and Large Molecules), By Biologics, By Therapeutic Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Non-Viral Drug Delivery Systems Market size was valued at USD 7,123 Million in 2023, expanding at a CAGR of 12.5% from 2024 to 2032.
Non-Viral Drug Delivery Systems: An Overview
Non-viral drug delivery systems refer to methods for delivering therapeutic agents, such as medications, DNA, or proteins, into the body without the use of viral vectors. Unlike viral vectors that utilize viruses to insert genetic information into cells, non-viral delivery systems employ a variety of artificial or natural carriers. These carriers can target specific cells or tissues, enhance stability, protect the therapeutic payload from degradation, and facilitate its release at the desired location of action.
Market Dynamics of the Non-Viral Drug Delivery Systems Market
Increasing Prevalence of Cancer to Propel Market Demand
The rising prevalence of cancer worldwide is expected to drive the growth of the non-viral drug delivery systems market during the forecast period. According to the World Health Organization, there were an estimated 20 million new cancer cases and 9.7 million cancer-related deaths in 2022. Additionally, it was estimated that 53.5 million people would be living five years after a cancer diagnosis. One in five individuals will develop cancer at some point in their lives, with one in nine men and one in twelve women dying from the disease. This increasing cancer burden is anticipated to boost the demand for advanced drug delivery systems, including non-viral methods, which offer targeted and efficient delivery of therapeutic agents.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NON-VIRAL DRUG DELIVERY SYSTEMS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Arcturus Therapeutics
Ø Bio-Path Holdings
Ø CureVac
Ø Entos Pharmaceuticals
Ø eTheRNA
Ø Matinas BioPharma
Ø MDimune
Ø PCI Biotech
GLOBAL NON-VIRAL DRUG DELIVERY SYSTEMS MARKET, BY MOLECULES- MARKET ANALYSIS, 2019 - 2032
Ø Small Molecules
Ø Large Molecules
GLOBAL NON-VIRAL DRUG DELIVERY SYSTEMS MARKET, BY BIOLOGICS- MARKET ANALYSIS, 2019 - 2032
Ø RNAi / mRNA
Ø DNA Oligonucleotides
Ø Antibodies
Ø Proteins / Peptides
GLOBAL NON-VIRAL DRUG DELIVERY SYSTEMS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032
Ø Infectious Diseases
Ø Oncological Disorders
Ø Genetic Disorders
Ø Neurological Disorders
Ø Hepatic Disorders
Ø Cardiovascular Disorders
Ø Others
GLOBAL NON-VIRAL DRUG DELIVERY SYSTEMS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Non-Viral Drug Delivery Systems Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Non-Viral Drug Delivery Systems Market Snippet by Molecules
2.1.2. Non-Viral Drug Delivery Systems Market Snippet by Biologics
2.1.3. Non-Viral Drug Delivery Systems Market Snippet by Therapeutic Area
2.1.4. Non-Viral Drug Delivery Systems Market Snippet by Country
2.1.5. Non-Viral Drug Delivery Systems Market Snippet by Region
2.2. Competitive Insights
3. Non-Viral Drug Delivery Systems Key Market Trends
3.1. Non-Viral Drug Delivery Systems Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Non-Viral Drug Delivery Systems Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Non-Viral Drug Delivery Systems Market Opportunities
3.4. Non-Viral Drug Delivery Systems Market Future Trends
4. Non-Viral Drug Delivery Systems Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Non-Viral Drug Delivery Systems Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Non-Viral Drug Delivery Systems Market Landscape
6.1. Non-Viral Drug Delivery Systems Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Non-Viral Drug Delivery Systems Market – By Molecules
7.1. Overview
7.1.1. Segment Share Analysis, By Molecules, 2023 & 2032 (%)
7.1.2. Small Molecules
7.1.3. Large Molecules
8. Non-Viral Drug Delivery Systems Market – By Biologics
8.1. Overview
8.1.1. Segment Share Analysis, By Biologics, 2023 & 2032 (%)
8.1.2. RNAi / mRNA
8.1.3. DNA Oligonucleotides
8.1.4. Antibodies
8.1.5. Proteins / Peptides
9. Non-Viral Drug Delivery Systems Market – By Therapeutic Area
9.1. Overview
9.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
9.1.2. Infectious Diseases
9.1.3. Oncological Disorders
9.1.4. Genetic Disorders
9.1.5. Neurological Disorders
9.1.6. Hepatic Disorders
9.1.7. Cardiovascular Disorders
9.1.8. Others
10. Non-Viral Drug Delivery Systems Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Non-Viral Drug Delivery Systems Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Non-Viral Drug Delivery Systems Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Non-Viral Drug Delivery Systems Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Non-Viral Drug Delivery Systems Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Non-Viral Drug Delivery Systems Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Molecules, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Biologics, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Non-Viral Drug Delivery Systems Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Arcturus Therapeutics
11.2.2. Bio-Path Holdings
11.2.3. CureVac
11.2.4. Entos Pharmaceuticals
11.2.5. eTheRNA
11.2.6. Matinas BioPharma
11.2.7. MDimune
11.2.8. PCI Biotech
12. 360 Degree Analyst View
13. Appendix
13.1. Research Therapeutic Areaology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
